NIKA PHARMACEUTICALS, INC (NIKA)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 Q4 '22: 0 Q1 '23: 0 Q2 '23: 0 Q3 '23: 0 Q4 '23: 0 Q4 '22 Q1 '23 Q2 '23 Q3 '23 Q4 '23

Gross Profit TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income TTM

-105K -70K -35K 0 35K 70K 105K Q3 '24: -84.1K Q4 '24: -89.2K Q1 '25: -56.2K Q2 '25: -52.1K Q3 '25: -51.8K Q4 '25: -76.4K Q1 '26: -76.8K Q2 '26: -78.1K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Net Income TTM

-105K -70K -35K 0 35K 70K 105K Q3 '24: -84.1K Q4 '24: -89.2K Q1 '25: -56.2K Q2 '25: -52.1K Q3 '25: -51.8K Q4 '25: -76.4K Q1 '26: -76.8K Q2 '26: -78.1K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow TTM

-180K -120K -60K 0 60K 120K 180K Q3 '24: -133.9K Q4 '24: -154.9K Q1 '25: -83.5K Q2 '25: -68.1K Q3 '25: -69.1K Q4 '25: -79.7K Q1 '26: -80.1K Q2 '26: -69.1K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Free Cash Flow TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Shares Outstanding Quarterly

0 400M 800M 1.2B Q1 '24: 876.1M Q2 '24: 1B Q3 '24: 1B Q1 '25: 1B Q2 '25: 1B Q3 '25: 1B Q1 '26: 1B Q2 '26: 1.1B Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 Q3 '24: 0.00 Q4 '24: 0.00 Q1 '25: 0.00 Q2 '25: 0.00 Q3 '25: 0.00 Q4 '25: 0.00 Q1 '26: 0.00 Q2 '26: 0.00 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.